Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.

The article presents information on the study of evaluation of anti-inflammatory effects of a fixed combination of extrafine beclomethasone dipropionate/formoterol (BDP/F) using adenosine monophosphate (AMP) for asthma. A double-blind, placebo-controlled study was conducted on mild asthmatic AMP sensitive patients. Exhaled nitric oxide was measured with forced expiratory volume. Analysis of covariance and variance was performed.